Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018:1–31.
   Web of Science ®Google Scholar
• Gaona-Gaona L, Molina-Jijón E, Tapia E, et al. Protective effect of sulforaphane pretreatment against cisplatin-induced liver and mitochondrial oxidant damage in rats. Toxicology. 2011;286(1–3):20–27. doi:10.1016/j.tox.2011.04.01421575670
   PubMed Web of Science ®Google Scholar
• Negrette-Guzmán M, Huerta-Yepez S, Vega M, et al. Sulforaphane induces differential modulation of TED MANUSCRIPT mitochondrial biogenesis and dynamics in normal cells and tumor cells. Food Chem Toxicol. 2017;100–107.
   Web of Science ®Google Scholar
• Choi S, Lew KL, Xiao H, et al. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis. 2007;28(1):151–162. doi:10.1093/carcin/bgl14416920735
   PubMed Web of Science ®Google Scholar
• Gamet-Payrastre L, Li P, Lumeau S, et al. Sulforaphane,a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 2000; 60(5):1426–1433.10728709
   PubMed Web of Science ®Google Scholar
• Pledgie-Tracy A, Sobolewski MD, Davidson NE. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther. 2007;6(3):1013–1021. doi:10.1158/1535-7163.MCT-06-049417339367
   PubMed Web of Science ®Google Scholar
• Wang M, Chen S, Wang S, et al. Effects of phytochemicals sulforaphane on uridine diphosphate-glucuronosyltransferase expression as well as cell-cycle arrest and apoptosis in human colon cancer caco-2 cells. Chin J Physiol. 2012;55(2):134–144. doi:10.4077/CJP.2012.BAA08522559738
   PubMed Web of Science ®Google Scholar
• Wang X, Govind S, Sajankila SP, et al. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food Res. 2011;55(10):1572–1581. doi:10.1002/mnfr.20100056021595016
   PubMed Web of Science ®Google Scholar
• Kerr C, Adhikary G, Grun D, et al. Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. Mol Carcinog. 2018;57(1):3–11. doi:10.1002/mc.2271428796401
   PubMed Web of Science ®Google Scholar
• Kallifatidis G, Labsch S, Rausch V, et al. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther. 2011;19(1):188–195. doi:10.1038/mt.2010.21620940707
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Shibuya M, Sugawara H, et al. Salinomycin,a new polyether antibiotic. J Antibiot. 1974;27(11):814–821. doi:10.7164/antibiotics.27.8144452657
   PubMed Web of Science ®Google Scholar
• Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138(4):645–659. doi:10.1016/j.cell.2009.06.03419682730
   PubMed Web of Science ®Google Scholar
• Zhou J, Li P, Xue X, et al. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicol Lett. 2013;222(2):139–145. doi:10.1016/j.toxlet.2013.07.02223916687
   PubMed Web of Science ®Google Scholar
• Ketola K, Hilvo M, Hyotylainen T, et al. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer. 2012;106(1):99–106. doi:10.1038/bjc.2011.53022215106
   PubMed Web of Science ®Google Scholar
• Kaplan F, Teksen F. Apoptotic effects of salinomycin on human ovarian cancer cell line (ovcar-3). Tumour Biol. 2016;37(3):3897–3903. doi:10.1007/s13277-015-4212-626476539
   PubMedGoogle Scholar
• Arafat K, Iratni R, Takahashi T, et al. Inhibitory effects of salinomycin on cell survival, colony growth, migration and invasion of human non-small cell lung cancer a549 and lnm35: involvement of nag-1. PLoS One. 2013;8(6):e66931. doi:10.1371/journal.pone.006693123805285
   PubMed Web of Science ®Google Scholar
• Al Dhaheri Y, Attoub S, Arafat K, et al. Salinomycin induces apoptosis and senescence in breast cancer: upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation. Biochim Biophys Acta. 2013;1830(4):3121–3135. doi:10.1016/j.bbagen.2013.01.01023352703
   PubMed Web of Science ®Google Scholar
• Parajuli B, GyoLee H, HoonKwon S, et al. Salinomycin inhibits Akt/NF-kB and induces apoptosis in cisplatin resistant ovarian cancer cells. Cancer Epidemiol. 2013;37(4):512–517. doi:10.1016/j.canep.2013.02.00823545383
   PubMed Web of Science ®Google Scholar
• Zhang GL, Liang Y, Zhou LJ, et al. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Lett. 2011;313(3):137–144. doi:10.1016/j.canlet.2011.05.03022030254
   PubMedGoogle Scholar
• Zhang Y, Zhang Q, Sun J, et al. The combination therapy of salinomycin and gefitinib using poly (d,l-lactic-co-glycolic acid)-poly (ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells. Onco Targets Ther. 2017;10:5653–5666. doi:10.2147/OTT.S14108329225473
   PubMed Web of Science ®Google Scholar
• Chou TC, Martin N. CompuSyn for Drug Combinations: PC Software and User’s Guide: A Computer Program for Quantitation of Synergism and Antagonism in Drug Combinations, and the Determination of IC50 and ED50 and LD50 Values. Paramus, NJ: ComboSyn; 2005 Available from: http://www. combosyn. com/for video demonstration.
   Google Scholar
• Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58(3):621–681. doi:10.1124/pr.58.3.1016968952
   PubMed Web of Science ®Google Scholar
• Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440–446. doi:10.1158/0008-5472.CAN-09-194720068163
   PubMed Web of Science ®Google Scholar
• Wang Q, Lu W, Yin T, et al. Calycosin suppresses TGF-β-induced epithelial-to-mesenchymal transition and migration by upregulating BATF2 to target PAI-1 via the Wnt and PI3K/Akt signaling pathways in colorectal cancer cells. J Exp Clin Cancer Res. 2019;38(1):240–252. doi:10.1186/s13046-019-1243-731174572
   PubMedGoogle Scholar
• Kim KY, Park KI, Kim SH, et al. Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells. Int J Mol Sci. 2017;18(5):1088–1101. doi:10.3390/ijms18051088
   PubMed Web of Science ®Google Scholar
• Han H, Chen W, Yang J, et al. Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery. Int J Nanomedicine. 2018;13:1297–1311. doi:10.2147/IJN.S14691729563788
   PubMed Web of Science ®Google Scholar
• Feng M, Feng J, Chen W, et al. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition. Mol Cancer. 2016;15(1):77–95. doi:10.1186/s12943-016-0564-927912767
   PubMedGoogle Scholar
• Zhou Q, Li W, Kong D, et al. DACH1 suppresses epithelial to mesenchymal transition (EMT) through notch1 pathway and reverses progestin resistance in endometrial carcinoma. Cancer Med. 2019;8(9):4380–4388. doi:10.1002/cam4.231731215145
   PubMed Web of Science ®Google Scholar
• Shusuke Y, Mano H, Toshiyuki S. Sulforaphane enhances apoptosis induced by Lactobacillus pentosus strain S-PT84 via the TNFα pathway in human colon cancer cells. Oncol Lett. 2019;18(4):4253–4261. doi:10.3892/ol.2019.1073931579089
   PubMed Web of Science ®Google Scholar
• Dominic B, Gabriele D, Martina B, Behrens J. Sulforaphane inhibits growth and blocks Wnt/β-catenin signaling of colorectal cancer cells. Oncotarget. 2018;9(74):33982–33994. doi:10.18632/oncotarget.2612530338040
   PubMedGoogle Scholar
• Liu K, Shih T, Kuo C, et al. Sulforaphane induces cell death through G2/M phase arrest and triggers apoptosis in HCT116 human colon cancer cells. Am J Chin Med. 2016;44(06):1289–1310. doi:10.1142/S0192415X1650072527627923
   PubMedGoogle Scholar
• Pereira L, Silva P, Duarte M, et al. Targeting colorectal cancer proliferation, stemness and metastatic potential using Brassicaceae extracts enriched in isothiocyanates: A 3D cell model-based study. Nutrients. 2017;9(4):368–394. doi:10.3390/nu9040368
   PubMed Web of Science ®Google Scholar
• Wang Y, Dacosta C, Wang W, et al. Synergy between sulforaphane and selenium in protection against oxidative damage in colonic CCD841 cells. ScienceDirect. 2015;35:610–617.
   Google Scholar
• Huczynski A, Janczak J, Antoszczak M, et al. Antiproliferative activity of salinomycin and its derivatives. Bioorg Med Chem Lett. 2012;22(23):7146–7150. doi:10.1016/j.bmcl.2012.09.06823079523
   PubMed Web of Science ®Google Scholar
• Koeck S, Amann A, Huber JM, et al. The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines. Oncol Lett. 2016;11(4):2946–2952. doi:10.3892/ol.2016.432327073581
   PubMed Web of Science ®Google Scholar
• Li R, Dong TT, Hu C, et al. Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway. Onco Targets Ther. 2017;10:1317–1325. doi:10.2147/OTT.S12646328280366
   PubMed Web of Science ®Google Scholar
• Ning H, Sun Z, Liu Y, et al. Insulin protects hepatic lipotoxicity by regulating ER stress through the PI3K/Akt/p53 involved pathway independently of autophagy inhibition. Nutrients. 2016;8(4):227.27104558
   PubMed Web of Science ®Google Scholar
• Qiu W, Leibowitz B, Zhang L, et al. Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene. 2010;29(11):1622–1632. doi:10.1038/onc.2009.45119966853
   PubMed Web of Science ®Google Scholar
• Fenouille N, Puissant A, Tichet M, et al. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Oncogene. 2011;30(49):4887–4900. doi:10.1038/onc.2011.19821685937
   PubMed Web of Science ®Google Scholar
• Schmitt CA, Lowe SW. Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo. Blood Cells Mol Dis. 2001;27(1):206–216. doi:10.1006/bcmd.2000.037211358381
   PubMed Web of Science ®Google Scholar
• Sonja W, Susan E, Gustavo P, et al. p53’s mitochondrial translocation and MOMP action is independent of puma and bax and severely disrupts mitochondrial membrane integrity. Cell Res. 2008;18(7):733–744. doi:10.1038/cr.2008.6218504456
   PubMed Web of Science ®Google Scholar
• Shyra J, David A, Steve K, et al. ×Phosphorylation of Bax Ser 184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem. 2004;279(20):21085–21095. doi:10.1074/jbc.M40006320014766748
   PubMed Web of Science ®Google Scholar
• Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Biochem Soc Trans. 2001;29(6):684–688. doi:10.1042/bst29068411709054
   PubMedGoogle Scholar
• Javier F, Guadalupe R, Ve´ronique R, et al. Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis. J Biol Chem. 1998;273(50):33533–33539. doi:10.1074/jbc.273.50.335339837934
   PubMed Web of Science ®Google Scholar